Last edition
News about "Licensing Deal "
Formosa Pharma Signs Licensing Deal with DAVI for Clobetasol Propionate Ophthalmic Suspension
The DÁVI licensing agreement includes upfront, commercialization milestones, and sales milestones, with additional considerations throughout the term of the agreement.
Licensing Deal | 04/11/2024 | By Aishwarya | 432
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members